Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 04, 2015 07:30 ET | Source: Affimed N.V.

Affimed Reports Financial Results for Second Quarter 2015

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} --Management provides update on...
July 28, 2015 06:10 ET | Source: Affimed N.V.

Affimed Announces Second Quarter 2015 Financial Results and Corporate Update Conference Call

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, July 28, 2015 -...
June 30, 2015 05:00 ET | Source: Affimed N.V.

Affimed Added to Russell 2000® Index

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, June 30, 2015 -...
June 23, 2015 05:00 ET | Source: Affimed N.V.

Affimed Announces Opening of US Operations and Key US-based Hires

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, June 23, 2015 -...
June 17, 2015 05:00 ET | Source: Affimed N.V.

AbCheck and Pierre Fabre Pharmaceuticals Enter Into Strategic Research Partnership

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Plzen, Czech Republic, and Castres,...
June 03, 2015 05:00 ET | Source: Affimed N.V.

Affimed Announces Newly Formed Scientific Advisory Board

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} -Renowned KOLs to Advance Affimed's NK-...
May 29, 2015 05:00 ET | Source: Affimed N.V.

Affimed ASCO Data for the CD33/CD3-TandAb Program Demonstrate that CD33 and CD3 Binding Affinities Correlate with Potent T-cell Activation and Cytotoxicity

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} -- TandAb platform enables reliable and rapid...
May 29, 2015 05:00 ET | Source: Affimed N.V.

Affimed ASCO Data Demonstrate Consistent Potency of NK-Cell-Engaging Combination Therapy with Checkpoint Modulators

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} --Affimed's lead NK-cell engager AFM13...
May 27, 2015 05:00 ET | Source: Affimed N.V.

Affimed to Present at the Jefferies 2015 Healthcare Conference - New York

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, May 27, 2015 -...
May 21, 2015 07:30 ET | Source: Affimed N.V.

Affimed Reports Financial Results for First Quarter 2015

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} -- Successful Follow-on Offering...